PBMC deconvolution, per-lineage Pearson r of inferred against measured shares
Infer the share of one lineage in 35 PBMC bulk RNA-seq samples and score the Pearson r against the share measured by single-cell RNA-seq of the same draws.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
2 recorded evaluations, 10 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
2 evaluations · 10 results. Different protocols are not a single leaderboard.
Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares · Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors)
Sorted by Pearson (Pearson r between inferred and measured B/plasma share across 35 PBMC bulks) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Pearson (Pearson r between inferred and measured B/plasma share across 35 PBMC bulks) | Pearson (Pearson r between inferred and measured CD4 T share across 35 PBMC bulks) | Pearson (Pearson r between inferred and measured CD8 T share across 35 PBMC bulks) | Pearson (Pearson r between inferred and measured Monocyte share across 35 PBMC bulks) | Pearson (Pearson r between inferred and measured NK share across 35 PBMC bulks) |
|---|---|---|---|---|---|
| Ladon, composition post-trained, PCA 64 + TabICL regressors (PBMC deconvolution)Evaluation | 0.88 (best in column) | 0.9 (best in column) | 0.79 (best in column) | 0.9 (best in column) | 0.89 (best in column) |
| CIBERSORT reimplementation (Ladon report)Evaluation | 0.39 | 0.78 | 0.77 | 0.76 | 0.27 |
All 10 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Method: CIBERSORT reimplementation (Ladon report) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.39 Pearson (Pearson r between inferred and measured B/plasma share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCIBERSORT, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'B/plasma', label 'r 0.88 0.39', second value (CIBERSORT) |
| Method: CIBERSORT reimplementation (Ladon report) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.78 Pearson (Pearson r between inferred and measured CD4 T share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCIBERSORT, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'CD4 T', label 'r 0.90 0.78', second value (CIBERSORT) |
| Method: CIBERSORT reimplementation (Ladon report) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.77 Pearson (Pearson r between inferred and measured CD8 T share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCIBERSORT, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'CD8 T', label 'r 0.79 0.77', second value (CIBERSORT) |
| Method: CIBERSORT reimplementation (Ladon report) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.76 Pearson (Pearson r between inferred and measured Monocyte share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCIBERSORT, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'Monocyte', label 'r 0.90 0.76', second value (CIBERSORT) |
| Method: CIBERSORT reimplementation (Ladon report) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.27 Pearson (Pearson r between inferred and measured NK share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCIBERSORT, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'NK', label 'r 0.89 0.27', second value (CIBERSORT) |
| Configuration: Ladon, composition post-trained, PCA 64 + TabICL regressors (PBMC deconvolution) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.88 Pearson (Pearson r between inferred and measured B/plasma share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceLadon, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'B/plasma', label 'r 0.88 0.39', first value (Ladon) |
| Configuration: Ladon, composition post-trained, PCA 64 + TabICL regressors (PBMC deconvolution) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.9 Pearson (Pearson r between inferred and measured CD4 T share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceLadon, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'CD4 T', label 'r 0.90 0.78', first value (Ladon) |
| Configuration: Ladon, composition post-trained, PCA 64 + TabICL regressors (PBMC deconvolution) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.79 Pearson (Pearson r between inferred and measured CD8 T share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceLadon, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'CD8 T', label 'r 0.79 0.77', first value (Ladon) |
| Configuration: Ladon, composition post-trained, PCA 64 + TabICL regressors (PBMC deconvolution) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.9 Pearson (Pearson r between inferred and measured Monocyte share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceLadon, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'Monocyte', label 'r 0.90 0.76', first value (Ladon) |
| Configuration: Ladon, composition post-trained, PCA 64 + TabICL regressors (PBMC deconvolution) | Protocol: PBMC deconvolution, per-lineage Pearson r of inferred against measured shares Dataset subset: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors) | 0.89 Pearson (Pearson r between inferred and measured NK share across 35 PBMC bulks) unitless · higher Uncertainty: Not reported by the source: No interval is printed for this value. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceLadon, PBMC deconvolution per-lineage Pearson r ladon-20261115-protocol-pbmc-lineage-pearson Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 17 (page 33), top panel 'NK', label 'r 0.89 0.27', first value (Ladon) |
Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 2
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Select a task-valid null control after reviewing inputs and metric
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Select an upstream conventional reference after reviewing the full protocol
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-11-21-adc15377fab2. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-11-21-adc15377fab2 · Record review: source checked
1 source record and release history
- Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Original source · Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID ladon-20261115-protocol-pbmc-lineage-pearson.
Source locator: Figure 17 (page 33) top panels, 'r' labels
Related records
- evaluates task: Cell-type deconvolution of bulk RNA-seq with single-cell references
- uses data: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors)
- used in: Giroux PBMC bulk RNA-seq test set for deconvolution (35 bulks, 17 donors)
- assessment: CIBERSORT, PBMC deconvolution per-lineage Pearson r
- assessment: Ladon, PBMC deconvolution per-lineage Pearson r